Literature DB >> 434208

Renal handling of calcium: influence of parathyroid hormone and 1,25-dihydroxyvitamin D3.

K Hugi, J P Bonjour, H Fleisch.   

Abstract

The influence of parathyroid hormone (PTH) and 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) on the renal Ca handling was studied in vitamin D-replete rats. The relation between plasma concentration ([Ca]P) and urinary Ca (UCaV/ml GF) was ascertained by clearance techniques over the [Ca]P range of 1.4-3.4 mM varied by infusion of Ca gluconate. Chronic thyroparathyroidectomy (TPTX) decreased the plasma Ca threshold from about 2.3 to 1.5 mM. Between [Ca]P 1.4 and 3.4 mM there was a linear increase in UCaV/ml GF corresponding to 35-50% of the increment in filtered load. In TPTX, PTH (2.5 IU/h i.v.) shifted the Ca threshold from 1.5 to 2.3 mM, without changing the slope of UCaV/ml GF on [Ca]P. The effect of TPTX on the renal Ca handling was not corrected by doses of 1,25(OH)2D3, which increased the intestinal Ca absorption of TPTX rats to normal level. In intact and TPTX rats disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) given at doses which inhibit the production of 1,25(OH)2D3 did not change the tubular Ca handling. Furthermore, 1,25(OH)2D3 had no effect in EHDP-treated TPTX rats. Therefore, tubular Ca handling does not appear to be altered in response to chronic endogenous variation or physiologic supplementation of 1,25(OH)2D3 in vitamin D-replete rats. This is in contrast to the marked alteration observed after TPTX or PTH administration.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 434208     DOI: 10.1152/ajprenal.1979.236.4.F349

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

Review 1.  Renal handling of calcium and phosphate.

Authors:  F Lang
Journal:  Klin Wochenschr       Date:  1980-10-01

Review 2.  Alterations in vitamin D metabolite, parathyroid hormone and fibroblast growth factor-23 concentrations in sclerostin-deficient mice permit the maintenance of a high bone mass.

Authors:  Zachary C Ryan; Theodore A Craig; Meghan McGee-Lawrence; Jennifer J Westendorf; Rajiv Kumar
Journal:  J Steroid Biochem Mol Biol       Date:  2014-11-22       Impact factor: 4.292

Review 3.  Clodronate in hypercalcemia of malignancy.

Authors:  J P Bonjour; R Rizzoli
Journal:  Calcif Tissue Int       Date:  1990       Impact factor: 4.333

4.  Vitamin D deficiency and renal calcium transport in the rat.

Authors:  M Yamamoto; Y Kawanobe; H Takahashi; E Shimazawa; S Kimura; E Ogata
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

Review 5.  Reduced renal calcium excretion in the absence of sclerostin expression: evidence for a novel calcium-regulating bone kidney axis.

Authors:  Rajiv Kumar; Volker Vallon
Journal:  J Am Soc Nephrol       Date:  2014-05-29       Impact factor: 10.121

6.  Inhibition of parathyroid hormone secretion and parathyroid hormone-independent diminution of tubular calcium reabsorption by WR-2721, a unique hypocalcemic agent.

Authors:  S Hirschel-Scholz; J Caverzasio; J P Bonjour
Journal:  J Clin Invest       Date:  1985-11       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.